1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. WEREWOLF THERAPEUTICS INC

Werewolf Therapeutics Inc

XNAS: HOWL

Download real time

1.16 -0.01 (-0.85%)

83.16% Fall from 52W High

168.4K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
4S
17W
1O
3T
52

Market Cap

Below industry Median
-0.7

PE TTM

Negative PE TTM
0

PEG TTM

0.6

Price to Book

Below industry Median
-0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Werewolf Therapeutics Inc is on 21 Mar 2025 for the purpose of Werewolf Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Werewolf Therapeutics Inc

The latest disclosure was made by Chulani Karunatilake in Werewolf Therapeutics Inc where a trade of 150,000 Stock Option (right to buy) done was reported to US exchanges on Jan. 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Chulani Karunatilake Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 150,000 150,000 - - Stock Option (right to buy)
Chulani Karunatilake Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 153,129 153,129 - - Stock Option (right to buy)
Ellen Lubman Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 131,900 131,900 - - Stock Option (right to buy)
Randi Isaacs Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 187,500 187,500 - - Stock Option (right to buy)
Randi Isaacs Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 68,151 68,151 - - Stock Option (right to buy)
Daniel J. Hicklin, Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 185,652 185,652 - - Stock Option (right to buy)
Daniel J. Hicklin, Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 592,690 592,690 - - Stock Option (right to buy)
Timothy W. Trost Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 60,358 60,358 - - Stock Option (right to buy)
Timothy W. Trost Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 150,000 150,000 - - Stock Option (right to buy)
Derek DiRocco Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 17,500 17,500 - - Stock Option (right to buy)
Luke B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 17,500 17,500 - - Stock Option (right to buy)
Michael Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 17,500 17,500 - - Stock Option (right to buy)
Briggs W. Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 17,500 17,500 - - Stock Option (right to buy)
Alon Lazarus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 17,500 17,500 - - Stock Option (right to buy)
Meeta Chatterjee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 17,500 17,500 - - Stock Option (right to buy)
Michael B. Atkins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 6,723 6,723 - - Stock Option (right to buy)
Atkins B. Michael Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 35,000 35,000 - - Stock Option (right to buy)
Karunatilake Chulani Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 150,000 150,000 - - Stock Option (right to buy)
Timothy Trost W. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 150,000 150,000 - - Stock Option (right to buy)
Randi Isaacs Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 200,000 200,000 - - Stock Option (right to buy)
Hicklin, Daniel J. Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 435,000 435,000 - - Stock Option (right to buy)
Cynthia Seidel-Dugan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 150,000 150,000 - - Stock Option (right to buy)
Lubman Ellen Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 131,900 131,900 - - Stock Option (right to buy)
Meeta Chatterjee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 13,200 13,200 - - Stock Option (right to buy)
Alon Lazarus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 13,200 13,200 - - Stock Option (right to buy)
Derek DiRocco Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 13,200 13,200 - - Stock Option (right to buy)
Briggs W. Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 13,200 13,200 - - Stock Option (right to buy)
Luke B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 13,200 13,200 - - Stock Option (right to buy)
Michael Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2023 13,200 13,200 - - Stock Option (right to buy)
Ellen Lubman Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 86,200 86,200 - - Stock Option (right to buy)
Chulani Karunatilake Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 103,600 103,600 - - Stock Option (right to buy)
Cynthia Seidel-Dugan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 115,900 115,900 - - Stock Option (right to buy)
Reid Leonard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 93,600 93,600 - - Stock Option (right to buy)
Randi Isaacs Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 103,300 103,300 - - Stock Option (right to buy)
Daniel J. Hicklin, Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 295,500 295,500 - - Stock Option (right to buy)
Timothy W. Trost Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 102,800 102,800 - - Stock Option (right to buy)
Briggs W. Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 11,600 11,600 - - Stock Option (right to buy)
Michael Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 11,600 11,600 - - Stock Option (right to buy)
Derek DiRocco Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 11,600 11,600 - - Stock Option (right to buy)
Alon Lazarus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 11,600 11,600 - - Stock Option (right to buy)
Meeta Chatterjee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 7,733 7,733 - - Stock Option (right to buy)
Chulani Karunatilake Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 136,000 136,000 - - Stock Option (right to buy)
Luke B. Evnin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 11,600 11,600 - - Stock Option (right to buy)
Reid Leonard Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 70,967 70,967 - - Stock Option (Right to Buy)
Timothy W. Trost Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 65,960 65,960 - - Stock Option (right to buy)
Daniel J. Hicklin, Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 215,888 215,888 - - Stock Option (right to buy)
Randi Isaacs Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 79,516 79,516 - - Stock Option (right to buy)
Ellen Lubman Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 51,088 51,088 - - Stock Option (right to buy)
Cynthia Seidel-Dugan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2022 15,532 83,631 - - Stock Option (right to buy)
Cynthia Seidel-Dugan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.77 per share. 06 Jan 2022 15,532 164,888 - 4.8 74,088 Common Stock
Cynthia Seidel-Dugan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.56 per share. 06 Jan 2022 24,199 149,356 - 1.6 37,750 Common Stock
Cynthia Seidel-Dugan Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Jan 2022 24,199 36,937 - - Stock Option (right to buy)
Cynthia Seidel-Dugan Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 79,516 79,516 - - Stock Option (right to buy)
Chulani Karunatilake Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 34,258 34,258 - - Stock Option (right to buy)
Meeta Chatterjee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 23,200 23,200 - - Stock Option (right to buy)
Chulani Karunatilake Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 272,000 272,000 - - Stock Option (right to buy)
Michael Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2021 23,200 23,200 - - Stock Option (right to buy)
Derek DiRocco Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 23,200 23,200 - - Stock Option (right to buy)
Briggs W. Morrison Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 23,200 23,200 - - Stock Option (right to buy)
Luke B. Evnin Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 23,200 23,200 - - Stock Option (Right to Buy)
Timothy W. Trost Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2021 247,812 247,812 - - Stock Option (right to buy)
Timothy W. Trost Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2021 54,756 54,756 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters